Repurposing glucagon-like peptide-1 receptor agonists for the treatment of neurodegenerative disorders
Moving beyond food noise to drug noise, GLP-1s are quieting the roar of addiction. Cai M, Choi T, Xie Y, Al-Aly Z
For comparison, Factor Meals another prepared meal delivery service that ships meals fresh and never frozen earned the same score
We dont know the length and frequency of side effects that the problems with the stuff people are buying online are multifold. Pharmaceutical company Eli Lilly (maker of Mounjaro) is running phase 3 clinical trials of the synthetic peptide, which has not been approved by any regulator globally
This approach is more honest about the role supplements can play and may provide genuine value by addressing nutritional gaps that GLP-1 medications can create
doi: 10.1038/s41467-021-24469-y 230 HuangLHeSCaiQLiFWangSTaoKet al